Femasys Inc (FEMY)

$1.34 0.01 (0.75%)

15:27 EDT FEMY Stock Quote Delayed 30 Minutes

FEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q4 2023

By InvestorPlace Earnings Mar 28, 2024

FEMY stock results show that Femasys beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

3 Micro-Cap Stocks Set to Explode Higher

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 97,917

Day's Range $1.33 - $1.41

52-Week Range $0.25 - $4.75

Dividend & Yield N/A (N/A)

FEMY Stock Predictions, Articles, and Femasys Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Oct 2, 2023

Pre-market stock movers are worth checking out on Monday as we start off the week with all the latest news this morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Sep 29, 2023

It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news traders need to know about on Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Sep 27, 2023

Pre-market stock movers are worth keeping track of and we're helping with the biggest winners and losers for Wednesday morning!

Why Is Femasys (FEMY) Stock Up 181% Today?

By William White, InvestorPlace Writer Sep 26, 2023

Femasys investors are celebrating on Tuesday after the company got approval from for its infertility treatment. This has FEMY stock rising.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Sep 26, 2023

Pre-market stock movers are among the biggest topics worth checking out on Tuesday and we have the latest news for investors!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Aug 2, 2023

It's time for another breakdown of the biggest pre-market stock movers as we check out all of the latest news for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 28, 2023

We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!

Why Is Femasys (FEMY) Stock Up 150% Today?

By Josh Enomoto, InvestorPlace Contributor Jul 27, 2023

With Femasys announcing a notice of allowance for its patent application, FEMY stock soared on its innovative birth control solution.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Mar 23, 2022

Rise and shine, trader! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Femasys filed to sell 18.11M shares of common stock for holders (NASDAQ:FEMY)

From Seeking Alpha Nov 30, 2023

Femasys (FEMY) files prospectus, signaling potential financial activities, but note that it is not an offer to sell.

Femasys appoints Liu as its chief medical officer (NASDAQ:FEMY)

From Seeking Alpha Nov 30, 2023

Femasys appoints James Liu as Chief Medical Officer. Company's shares down 0.7% in pre-market trade.

Femasys to showcase FemBloc, other products at medical meeting (FEMY)

From Seeking Alpha Oct 25, 2023

Femasys (FEMY) will showcase its products, including FemBloc, a non-surgical permanent birth control, at an upcoming medical conference in Nashville.

Femasys regains Nasdaq compliance (NASDAQ:FEMY)

From Seeking Alpha Oct 11, 2023

Biomedical company Femasys regains compliance with Nasdaq's minimum bid price requirement, ensuring continued listing on The Nasdaq Capital Market.

5 of the Most Active Penny Stocks Worth Your Precious Time

From MarketBeat Oct 5, 2023

These are five of the Most Active Penny Stocks in October that investors may find worthy of investment for 2024 and beyond

Maxim Group Keeps Their Buy Rating on Femasys (FEMY)

From TipRanks Dec 1, 2022

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Femasys (FEMY – Research Report), with a price target of...

ADVERTISEMENT